Stockwinners Market Radar for December 13, 2020 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:54 EST Fly Intel: Top five weekend stock stories - Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Pfizer (PFE) and BioNTech (BNTX) have announced that the Food and Drug Administration has authorized the emergency use of the mRNA vaccine, BNT162b2, against COVID-19 in individuals 16 years of age or older. The vaccine is now authorized under an Emergency Use Authorization while Pfizer and BioNTech gather additional data and prepare to file a planned Biologics License Application with the FDA for a possible full regulatory approval in 2021. Under Operation Warp Speed, the Department of Defense in partnership with agencies within the Department of Health and Human Services, including the U.S. Centers for Disease Control and Prevention, will manage allocation and distribution of the vaccine in the U.S., the companies said in a statement. Following the announcement, FedEx Express, a subsidiary of FedEx (FDX), said that operations are in motion to transport its first shipments of COVID-19 vaccines. Express will begin transport of the vaccine using its FedEx Priority Overnight service supported by FedEx Priority Alert advanced monitoring. Meanwhile, UPS (UPS) also announced its involvement and full support of distribution efforts for Pfizer-BioNTech's COVID-19 vaccine as part of Operation Warp Speed. Pfizer's and BioNTech's vaccine. UPS will move the Pfizer-BioNTech COVID-19 vaccine within the first days to states designated by Pfizer based on orders received by Operation Warp Speed and CDC officials. 2. AstraZeneca (AZN) and Alexion Pharmaceuticals (ALXN) have entered into a definitive agreement for AstraZeneca to acquire Alexion. Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares, or ADSs, with each ADS representing one-half of one ordinary share of AstraZeneca, as evidenced by American Depositary Receipts, or ADRs, for each Alexion share. Based on AstraZeneca's reference average ADR price of $54.14, this implies total consideration to Alexion shareholders of $39B or $175 per share. 3. Electric vehicles are the future of the auto industry, so it's no surprise they have captured Wall Street's imagination, Al Root wrote in this week's edition of Barron's. Xpeng's (XPEV) ADRs have tripled, Li Auto (LI) is up 180% from its July 30 IPO and Nio's (NIO) ADRs are up nearly 600%, the author noted, adding that while It can be hard to part with a stock after such enormous gains, taking profits in the Chinese EV trio looks like the prudent thing to do. High valuations aren't a reason to sell a stock-just ask anyone who bet against Tesla (TSLA), whose shares have soared about 650% this year. But China's EV upstarts face potential risks that don't appear to be factored into their stock prices, Root contended. 4. Gaming company Roblox (RBLX) had been preparing to go public this month but has decided to delay its initial public offering until next year, The New York Times' Kellen Browning reported. Meanwhile, Affirm Holdings (AFRM) is also postponing its initial public offering, The Wall Street Journal's Maureen Farrell and Cara Lombardo report, citing people familiar with the matter. 5. Mercury General's (MCY), Disney (DIS), and Starbucks (SBUX) saw positive mentions in this week's edition of Barron's.

10:27 EST CDC Committee recommends Pfizer, BioNTech COVID vaccine for '16 years and older' - Pfizer (PFE) and BioNTech (BNTX) announced that the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices voted to recommend the use of the Pfizer-BioNTech COVID-19 vaccine in people 16 years of age and older under the Emergency Use Authorization issued by the U.S. Food and Drug Administration. This ACIP vote follows the December 1, 2020, ACIP recommendation for a Phase 1a rollout where first priority of COVID-19 vaccines is given to health care personnel treating patients, and residents in nursing homes and other long-term care facilities. ACIP advises the CDC on the types of populations and circumstances for which vaccines should be used. The advisors based the recommendation on the scientific evidence supporting the COVID-19 vaccine, including data from a Phase 3 clinical study announced last month and published in The New England Journal of Medicine on December 10, 2020, as well as on interim guidance that ACIP made on December 1, 2020 regarding the allocation of initial vaccine doses. The vaccine was authorized by the FDA on December 11, 2020 under an EUA while Pfizer and BioNTech gather additional data and prepare to file a planned Biologics License Application with the FDA for a possible full regulatory approval in 2021. The first vaccine supplies are being prepared to ship from Pfizer's Kalamazoo, MI site, and will be distributed by the U.S. Department of Defense in partnership with agencies within the Department of Health and Human Services, including the CDC, to government-designated facilities across the country.

10:13 EST UPS to support distribution of approved vaccine as part of Operation Warp Speed - UPS (UPS) announced its involvement and full support of distribution efforts for Pfizer (PFE)-BioNTech's (BNTX) COVID-19 vaccine as part of Operation Warp Speed. Pfizer's and BioNTech's vaccine, approved through a U.S. Food and Drug Administration emergency use authorization, is the first to be deployed in a months-long global race to develop safe vaccines to combat the spread of the COVID-19 virus. UPS will move the Pfizer-BioNTech COVID-19 vaccine within the first days to states designated by Pfizer based on orders received by Operation Warp Speed and CDC officials. "This is the moment of truth we've been waiting for at UPS," says Wes Wheeler, president of UPS Healthcare. "We have spent months strategizing with Operation Warp Speed officials and our healthcare customers on efficient vaccine logistics, and the time has arrived to put the plan into action." Pfizer-BioNTech COVID-19 vaccines will originate from storage sites in Michigan and Wisconsin. The vaccines will be transported to UPS Worldport facilities in Louisville, where they will be expedited Next Day Air to select destinations, including hospitals, clinics and other medical facilities, to inoculate healthcare workers.

10:06 EST Walgreens issues statement regarding FDA EUA of COVID-19 vaccine - Walgreens Boots Alliance (WBA) said in a statement that, "The announcement from the FDA providing Pfizer [PFE] with emergency use authorization on its COVID-19 vaccine is a historic milestone and important step toward ending the pandemic. We have the opportunity to turn the tide on a pandemic that has wreaked havoc on our lives and livelihoods. Walgreens is preparing to immediately bring vaccines to high-priority populations, as determined by the Centers for Disease Control and federal and state governments. These include long-term care facility residents and staff, as well as healthcare workers. We will be collaborating with nearly 35,000 skilled nursing and assisted living facilities nationwide that have selected Walgreens as their vaccine provider. As states finalize their distribution plans, we believe we can begin administration in some long-term care facilities on the date of activation approved by the CDC to help ensure those most vulnerable are among the first to be protected against the virus. With our nationwide store footprint, extensive vaccine experience and pharmacy team members embedded in communities across the country, we are prepared to expand access to the general population through our more than 9,000 stores once COVID-19 vaccines become available more broadly in 2021. We will continue to work closely with Operation Warp Speed, as well as the CDC, Health and Human Services and federal and state governments to ensure the administration of COVID-19 vaccines across the nation as soon as possible."